Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Venous Thromboembolism × bemiparin × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Pulmonary Embolism 1 Neoplasms 1 Hemorrhage 1

Interventions

Rivaroxaban 5 apixaban 4 Dalteparin 4 Enoxaparin 3 edoxaban 2 abelacimab 2 Tinzaparin 2 MAA868 2 Heparin, Low-Molecular-Weight 2 Dabigatran 2 calcium heparin 1 betrixaban 1 bemiparin 1 Warfarin 1 Heparin 1 Gemcitabine 1 Fondaparinux 1 AVE 5026 1 ALT-836 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00219973 2010-04-28

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Rovi Pharmaceuticals Laboratories

Phase 3 Completed

Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡